Download PDF
CC BY 4.0 · Journal of Child Science 2021; 11(01): e173-e177
DOI: 10.1055/s-0041-1731337
Original Article

Serial Thyroid Function Test in Very Low Birth Weight Neonates

Birendra Pradhan 
1   Department of Pediatrics, Veer Surendra Sai Institute of Medical Sciences and Research, Burla, Odisha, India
,
Santosh Kumar Panda 
2   Department of Pediatrics, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India
,
Deepti Damayanty Pradhan 
2   Department of Pediatrics, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India
,
Manas Kumar Nayak 
2   Department of Pediatrics, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India
,
Soumini Rath 
2   Department of Pediatrics, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India
,
Sonali Sahoo 
3   Department of Physiology, Veer Surendra Sai Institute of Medical Sciences and Research, Burla, Odisha, India
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Thyroid dysfunction is more common in preterm and low birth weight infants, and may be missed if thyroid function test (TFT) is not repeated. Thus, we attempted to study the pattern of thyroid function among very low birth weight (VLBW) infants with birth weight less than 1,500 g by serial TFTs. Serum free thyroxine (FT4) and thyrotropin (thyroid-stimulating hormone [TSH]) levels of VLBW infants were tested on fifth to seventh days of life and repeated after 4 weeks of age. Based on serial FT4 and TSH results, abnormal TFT was classified into four groups—transient hypothyroxinemia of prematurity (THOP), transient hyperthyrotropinemia (THT), delayed TSH rise, and overt congenital hypothyroidism (CH). Stata 15.1 (Stata Corp, Texas, United States) was used for analysis. Ninety-six VLBW infants were enrolled with mean gestational age of 30.5 ± 2.7 weeks and median (interquartile range) birth weight of 1,200 (317) g. Out of 96 cases, 30 (31.2%) infants had abnormal TFT. Ten (10.4%) infants had THOP, 7 (7.3%) infants had THT, 11 (11.5%) infants had delayed TSH rise, and 2 (2.1%) infants had overt CH. There were no significant differences in demographic profile and clinical characteristics between neonates with normal and abnormal TFTs. Five infants required levothyroxine supplementation (two infants with overt CH and three infants with delayed TSH rise). VLBW neonates have higher incidence of CH and delayed rise of TSH in this study. In resource-limited settings, repeating TFTs at least once after 4 weeks of age may be suggested to identify delayed rise of TSH which may need intervention.

Keywords

very low birth weight infant - thyroid function tests - congenital hypothyroidism - premature infants


Publication History

Received: 29 November 2020

Accepted: 20 May 2021

Article published online:
26 June 2021

© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Simoneau-Roy J, Marti S, Deal C, Huot C, Robaey P, Van Vliet G. Cognition and behavior at school entry in children with congenital hypothyroidism treated early with high-dose levothyroxine. J Pediatr 2004; 144 (06) 747-752
    CrossrefPubMedGoogle Scholar
  • 2 LaFranchi SH. Newborn screening strategies for congenital hypothyroidism: an update. J Inherit Metab Dis 2010; 33 (Suppl. 02) S225-S233
    CrossrefPubMedGoogle Scholar
  • 3 ICMR Task Force on Inherited Metabolic Disorders. Newborn screening for congenital hypothyroidism and congenital adrenal hyperplasia. Indian J Pediatr 2018; 85 (11) 935-940
    CrossrefPubMedGoogle Scholar
  • 4 van Wassenaer AG, Kok JH. Hypothyroxinaemia and thyroid function after preterm birth. Semin Neonatol 2004; 9 (01) 3-11
    CrossrefPubMedGoogle Scholar
  • 5 LaFranchi S. Thyroid function in the preterm infant. Thyroid 1999; 9 (01) 71-78
    CrossrefPubMedGoogle Scholar
  • 6 Fisher DA. Thyroid function and dysfunction in premature infants. Pediatr Endocrinol Rev 2007; 4 (04) 317-328
    PubMedGoogle Scholar
  • 7 Kim HR, Jung YH, Choi CW, Chung HR, Kang MJ, Kim BI. Thyroid dysfunction in preterm infants born before 32 gestational weeks. BMC Pediatr 2019; 19 (01) 391
    CrossrefPubMedGoogle Scholar
  • 8 Armanian AM, Kelishadi R, Barekatain B, Salehimehr N, Feizi A. Frequency of thyroid function disorders among a population of very-low-birth-weight premature infants. Iran J Neonatol 2016; 7 (03) 9-16
    PubMedGoogle Scholar
  • 9 Williams FL, Simpson J, Delahunty C. et al; Collaboration from the Scottish Preterm Thyroid Group. Developmental trends in cord and postpartum serum thyroid hormones in preterm infants. J Clin Endocrinol Metab 2004; 89 (11) 5314-5320
    CrossrefPubMedGoogle Scholar
  • 10 Desai MP, Sharma R, Riaz I, Sudhanshu S, Parikh R, Bhatia V. Newborn screening guidelines for congenital hypothyroidism in India: recommendations of the Indian Society for Pediatric and Adolescent Endocrinology (ISPAE) - Part I: screening and confirmation of diagnosis. Indian J Pediatr 2018; 85 (06) 440-447
    CrossrefPubMedGoogle Scholar
  • 11 Léger J, Olivieri A, Donaldson M. et al; ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE, Congenital Hypothyroidism Consensus Conference Group. European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. J Clin Endocrinol Metab 2014; 99 (02) 363-384
    CrossrefPubMedGoogle Scholar
  • 12 Rose SR, Brown RS, Foley T. et al; American Academy of Pediatrics, Section on Endocrinology and Committee on Genetics, American Thyroid Association, Public Health Committee, Lawson Wilkins Pediatric Endocrine Society. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics 2006; 117 (06) 2290-2303
    CrossrefPubMedGoogle Scholar
  • 13 Woo HC, Lizarda A, Tucker R. et al. Congenital hypothyroidism with a delayed thyroid-stimulating hormone elevation in very premature infants: incidence and growth and developmental outcomes. J Pediatr 2011; 158 (04) 538-542
    CrossrefPubMedGoogle Scholar
  • 14 Chung HR, Shin CH, Yang SW. et al. High incidence of thyroid dysfunction in preterm infants. J Korean Med Sci 2009; 24 (04) 627-631
    CrossrefPubMedGoogle Scholar
  • 15 Lee JH, Kim SW, Jeon GW, Sin JB. Thyroid dysfunction in very low birth weight preterm infants. Korean J Pediatr 2015; 58 (06) 224-229
    CrossrefPubMedGoogle Scholar
  • 16 Delahunty C, Falconer S, Hume R. et al; Scottish Preterm Thyroid Group. Levels of neonatal thyroid hormone in preterm infants and neurodevelopmental outcome at 5 1/2 years: millennium cohort study. J Clin Endocrinol Metab 2010; 95 (11) 4898-4908
    CrossrefPubMedGoogle Scholar
  • 17 Dilli D, Eras Z, Andiran N, Dilmen U, Sakrucu ED. Neurodevelopmental evaluation of very low birth weight infants with transient hypothyroxinemia at corrected age of 18-24 months. Indian Pediatr 2012; 49 (09) 711-715
    CrossrefPubMedGoogle Scholar
  • 18 Perlman JM. Neurobehavioral deficits in premature graduates of intensive care--potential medical and neonatal environmental risk factors. Pediatrics 2001; 108 (06) 1339-1348
    CrossrefPubMedGoogle Scholar
  • 19 Gressens P, Rogido M, Paindaveine B, Sola A. The impact of neonatal intensive care practices on the developing brain. J Pediatr 2002; 140 (06) 646-653
    CrossrefPubMedGoogle Scholar
  • 20 Valerio PG, van Wassenaer AG, de Vijlder JJ, Kok JH. A randomized, masked study of triiodothyronine plus thyroxine administration in preterm infants less than 28 weeks of gestational age: hormonal and clinical effects. Pediatr Res 2004; 55 (02) 248-253
    CrossrefPubMedGoogle Scholar
  • 21 Osborn DA. Thyroid hormones for preventing neurodevelopmental impairment in preterm infants. Cochrane Database Syst Rev 2001; (04) CD001070
    PubMedGoogle Scholar
  • 22 Chung ML. Incidence and risk factor of permanent hypothyroidism in preterm infants. J Neonatal Biol 2017; 6: 254
    CrossrefPubMedGoogle Scholar
  • 23 Chung ML, Yoo HW, Kim KS. et al. Thyroid dysfunctions of prematurity and their impacts on neurodevelopmental outcome. J Pediatr Endocrinol Metab 2013; 26 (5-6): 449-455
    CrossrefPubMedGoogle Scholar
  • 24 Zung A, Tenenbaum-Rakover Y, Barkan S. et al. Neonatal hyperthyrotropinemia: population characteristics, diagnosis, management and outcome after cessation of therapy. Clin Endocrinol (Oxf) 2010; 72 (02) 264-271
    CrossrefPubMedGoogle Scholar
  • 25 Kaluarachchi DC, Colaizy TT, Pesce LM, Tansey M, Klein JM. Congenital hypothyroidism with delayed thyroid-stimulating hormone elevation in premature infants born at less than 30 weeks gestation. J Perinatol 2017; 37 (03) 277-282
    CrossrefPubMedGoogle Scholar
  • 26 Kaluarachchi DC, Allen DB, Eickhoff JC, Dawe SJ, Baker MW. Increased congenital hypothyroidism detection in preterm infants with serial newborn screening. J Pediatr 2019; 207: 220-225
    CrossrefPubMedGoogle Scholar
  • 27 McGrath N, Hawkes CP, Mayne P, Murphy NP. Optimal timing of repeat newborn screening for congenital hypothyroidism in preterm infants to detect delayed thyroid-stimulating hormone elevation. J Pediatr 2019; 205: 77-82
    CrossrefPubMedGoogle Scholar
  • 28 Vigone MC, Caiulo S, Di Frenna M. et al. Evolution of thyroid function in preterm infants detected by screening for congenital hypothyroidism. J Pediatr 2014; 164 (06) 1296-1302
    CrossrefPubMedGoogle Scholar
  • 29 Srinivasan R, Harigopal S, Turner S, Cheetham T. Permanent and transient congenital hypothyroidism in preterm infants. Acta Paediatr 2012; 101 (04) e179-e182
    CrossrefPubMedGoogle Scholar
  • 30 Lafranchi SH. Congenital hypothyroidism: delayed detection after birth and monitoring treatment in the first year of life. J Pediatr 2011; 158 (04) 525-527
    CrossrefPubMedGoogle Scholar
  • 31 Deladoëy J, Ruel J, Giguère Y, Van Vliet G. Is the incidence of congenital hypothyroidism really increasing? A 20-year retrospective population-based study in Québec. J Clin Endocrinol Metab 2011; 96 (08) 2422-2429
    CrossrefPubMedGoogle Scholar